Unconfigured Ad

Collapse

Any non-primary sequence heritable modification of genetic material. ChIP-SEQ, DNA methylation (Bisulfite-SEQ), chromatin modifications (methylation, acetylation, etc), non coding RNA.

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-03-2008, 12:50 AM
20 responses
88,659 views
0 reactions
Last Post sameet
by sameet
 
Started by ECO, 12-23-2008, 07:35 PM
0 responses
6,925 views
0 reactions
Last Post ECO
by ECO
 
Started by Newsbot!, 12-17-2008, 06:03 AM
0 responses
3,201 views
0 reactions
Last Post Newsbot!  
Started by frozenlyse, 12-10-2008, 05:21 PM
2 responses
5,115 views
0 reactions
Last Post frozenlyse  
Started by athos, 09-19-2008, 12:56 AM
2 responses
5,593 views
0 reactions
Last Post weiweideng  
Started by hongyan, 09-24-2008, 08:28 AM
3 responses
8,954 views
0 reactions
Last Post Chipper
by Chipper
 
Started by What_Da_Seq, 08-01-2008, 12:09 PM
5 responses
63,662 views
0 reactions
Last Post Chipper
by Chipper
 
No topics found.
  • Filter
  • Time
Clear All
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.

Recent Articles

Collapse

  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    Yesterday, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM
  • SEQadmin2
    Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by SEQadmin2


    I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.

    Here are nine questions we think about, in roughly the order they matter, before...
    06-18-2026, 07:11 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:08 AM
0 responses
6 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...